(Q42234354)

19 October 2017

title

Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta (English)

1 reference

19 October 2017

1 reference

14

1 reference

19 October 2017

12

Stefan Zeuzem

1 reference

19 October 2017

Boris A Ratsch

4

0 references

Michael Manns

15

object named as

Michael P Manns

1 reference

19 October 2017

16

Heiner Wedemeyer

1 reference

19 October 2017

13

Markus Cornberg

1 reference

19 October 2017

Benjamin Heidrich

1

1 reference

19 October 2017

Cihan Yurdaydın

2

1 reference

19 October 2017

Gökhan Kabaçam

3

1 reference

19 October 2017

Kalliopi Zachou

5

1 reference

19 October 2017

Birgit Bremer

6

1 reference

19 October 2017

George N Dalekos

7

1 reference

19 October 2017

Andreas Erhardt

8

1 reference

19 October 2017

Fehmi Tabak

9

1 reference

19 October 2017

Kendal Yalcin

10

1 reference

19 October 2017

Selim Gürel

11

1 reference

19 October 2017

HIDIT-1 Study Group

17

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 July 2014

1 reference

19 October 2017

1 reference

19 October 2017

volume

60

1 reference

19 October 2017

issue

1

1 reference

19 October 2017

page(s)

87-97

1 reference

Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead

19 October 2017

cites work

1 reference

Natural history and treatment of chronic delta hepatitis

21 January 2018

1 reference

Treatment options for hepatitis delta virus infection

21 January 2018

1 reference

21 January 2018

Hepatitis delta virus

1 reference

Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D.

21 January 2018

1 reference

Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis

21 January 2018

1 reference

Virological and clinical characteristics of delta hepatitis in Central Europe

21 January 2018

1 reference

Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses.

21 January 2018

1 reference

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

21 January 2018

1 reference

Treatment of chronic hepatitis delta with pegylated interferon-alpha2b

21 January 2018

1 reference

Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta.

21 January 2018

1 reference

Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis.

21 January 2018

1 reference

Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

21 January 2018

1 reference

Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: a propensity score analysis

21 January 2018

1 reference

Accuracy of risk scores for patients with chronic hepatitis B receiving entecavir treatment

21 January 2018

1 reference

Outcome of sustained virological responders with histologically advanced chronic hepatitis C.

21 January 2018

1 reference

Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.

21 January 2018

1 reference

Natural history of acute and chronic hepatitis C.

21 January 2018

1 reference

Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis.

21 January 2018

1 reference

Establishment of a novel quantitative hepatitis D virus (HDV) RNA assay using the Cobas TaqMan platform to study HDV RNA kinetics

21 January 2018

1 reference

Correlation between the Elecsys HBsAg II assay and the Architect assay for the quantification of hepatitis B surface antigen (HBsAg) in the serum.

21 January 2018

1 reference

A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma.

21 January 2018

1 reference

Outcome of chronic delta hepatitis in Italy: a long-term cohort study

21 January 2018

1 reference

Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study

21 January 2018

1 reference

Reappearance of hepatitis D virus (HDV) replication in chronic hepatitis B virus carrier chimpanzees rechallenged with HDV.

21 January 2018

1 reference

EASL Clinical Practice Guidelines: management of hepatitis C virus infection

21 January 2018

1 reference

Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis delta antigen persistence after liver transplantation.

21 January 2018

1 reference

Hepatitis D virus-specific cytokine responses in patients with chronic hepatitis delta before and during interferon alfa-treatment.

21 January 2018

1 reference

Patterns of viral decline during PEG-interferon alpha-2b therapy in HBeAg-positive chronic hepatitis B: Relation to treatment response

21 January 2018

1 reference

Interferon alpha-2b with and without ribavirin in the treatment of hepatitis B e antigen-positive chronic hepatitis B: a randomized study.

21 January 2018

1 reference

Resolution of chronic hepatitis Delta after 1 year of combined therapy with pegylated interferon, tenofovir and emtricitabine

21 January 2018

1 reference

Myristoylated PreS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytes

21 January 2018

1 reference

The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus.

21 January 2018

1 reference

Optimized HBsAg titer monitoring improves interferon therapy in patients with chronic hepatitis delta.

21 January 2018

1 reference

Efficacy of peginterferon alpha-2b in chronic hepatitis delta: Relevance of quantitative RT-PCR for follow-up

21 January 2018

1 reference

Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study

21 January 2018

1 reference

21 January 2018

Hepatitis delta virus

1 reference

7 January 2021

Peginterferon plus adefovir versus either drug alone for hepatitis delta

1 reference

7 January 2021

HBeAg-positive hepatitis delta: virological patterns and clinical long-term outcome

1 reference

7 January 2021

Treatment of chronic hepatitis D with interferon alfa-2a

1 reference

7 January 2021

Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis

1 reference

7 January 2021

Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B

1 reference

7 January 2021

Resolution of chronic delta hepatitis after 12 years of interferon alfa therapy

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.27102

1 reference

19 October 2017

1 reference